Global Medicinal Fungi

Medicinal Fungi Comprehensive Study by Type (Micafungin, Mycophenolate, Rosuvastatin, Others), Application (Household, Commercial, Industrial), Form (Powder, Whole, Slices, Extract), End-use (Antioxidants, Immune enhancers, Anti-cancer, Skincare) Players and Region - Global Market Outlook to 2030

Medicinal Fungi Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Medicinal Fungi
Medicinal fungi are fungi that contain metabolites or can be induced to produce metabolites through biotechnology to develop prescription drugs such as antibiotics, anti-cancer drugs, psychotropic drugs, cholesterol and ergosterol synthesis inhibitors, immunosuppressants and fungicides. The factors such as the Increased Application of Fungi in Numerous Drugs and Increasing Consumer Interest in Healthy Food Products are driving the global Medicinal Fungi market. In addition, Increased Research and Development Funding also fueling the market growth. However, Lack of Effective Production Skills and Less Awareness about the Health Benefits of Fungi are the restraining factors for the Medicinal Fungi market.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Medicinal Fungi market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Amino Up Chemical Co., Ltd. (Japan), Nammex (Canada), Baikal Herbs Ltd. (Russia), Hangzhou Johncan Mushroom Bio-Technology Co., Ltd (China), Aloha Medicinals, Inc. (United States), Fungi Perfecti, Llc (United States), Undersun Biomedtech Corp (United States) and NutraGenesis, LLC (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Naturalin Bio-Resources Co., Ltd (China), Lingonberry Group (USA) Inc. (United States) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Medicinal Fungi market by Type (Micafungin, Mycophenolate, Rosuvastatin and Others), Application (Household, Commercial and Industrial) and Region.



On the basis of geography, the market of Medicinal Fungi has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Form, the sub-segment i.e. Powder will boost the Medicinal Fungi market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-use, the sub-segment i.e. Antioxidants will boost the Medicinal Fungi market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increased Research and Development Funding

Market Growth Drivers:
Increased Application of Fungi in Numerous Drugs and Increasing Consumer Interest in Healthy Food Products

Challenges:
Less Awareness about Health Benefits of Fungi

Restraints:
Lack of Effective Production Skills

Opportunities:
Growing Demand from End-users and Robust Increase in the Distribution Channels

Market Leaders and their expansionary development strategies
In March 2023, GSK plc, announced they have entered into an exclusive licence agreement for Brexafemme (ibrexafungerp tablets), a US FDA approved, first-in-class antifungal for the treatment of vulvovaginal candidiasis (VVC) and for reduction in the incidence of recurrent VVC (RVVC). This exclusive licence agreement gives GSK rights to commercialise Brexafemme for VVC and RVVC while continuing to develop ibrexafungerp, which is in phase III clinical trials for the potential treatment of invasive candidiasis (IC), a life-threatening fungal infection.
In September 2023, BDR Pharmaceutical announced the launch of Zisavel capsules for treating invasive aspergillosis and mucormycosis, both fungal infections. This generic medication, classified under azole antifungals, is offered at one-third of the price of the current therapy provided by the innovators.


Key Target Audience
Medicinal Fungi Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Micafungin
  • Mycophenolate
  • Rosuvastatin
  • Others
By Application
  • Household
  • Commercial
  • Industrial
By Form
  • Powder
  • Whole
  • Slices
  • Extract

By End-use
  • Antioxidants
  • Immune enhancers
  • Anti-cancer
  • Skincare

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Application of Fungi in Numerous Drugs
      • 3.2.2. Increasing Consumer Interest in Healthy Food Products
    • 3.3. Market Challenges
      • 3.3.1. Less Awareness about Health Benefits of Fungi
    • 3.4. Market Trends
      • 3.4.1. Increased Research and Development Funding
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Medicinal Fungi, by Type, Application, Form, End-use and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Medicinal Fungi (Value)
      • 5.2.1. Global Medicinal Fungi by: Type (Value)
        • 5.2.1.1. Micafungin
        • 5.2.1.2. Mycophenolate
        • 5.2.1.3. Rosuvastatin
        • 5.2.1.4. Others
      • 5.2.2. Global Medicinal Fungi by: Application (Value)
        • 5.2.2.1. Household
        • 5.2.2.2. Commercial
        • 5.2.2.3. Industrial
      • 5.2.3. Global Medicinal Fungi by: Form (Value)
        • 5.2.3.1. Powder
        • 5.2.3.2. Whole
        • 5.2.3.3. Slices
        • 5.2.3.4. Extract
      • 5.2.4. Global Medicinal Fungi by: End-use (Value)
        • 5.2.4.1. Antioxidants
        • 5.2.4.2. Immune enhancers
        • 5.2.4.3. Anti-cancer
        • 5.2.4.4. Skincare
      • 5.2.5. Global Medicinal Fungi Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Medicinal Fungi: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Amino Up Chemical Co., Ltd. (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Nammex (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Baikal Herbs Ltd. (Russia)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Hangzhou Johncan Mushroom Bio-Technology Co., Ltd (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Aloha Medicinals, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Fungi Perfecti, Llc (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Undersun Biomedtech Corp (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. NutraGenesis, LLC (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Medicinal Fungi Sale, by Type, Application, Form, End-use and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Medicinal Fungi (Value)
      • 7.2.1. Global Medicinal Fungi by: Type (Value)
        • 7.2.1.1. Micafungin
        • 7.2.1.2. Mycophenolate
        • 7.2.1.3. Rosuvastatin
        • 7.2.1.4. Others
      • 7.2.2. Global Medicinal Fungi by: Application (Value)
        • 7.2.2.1. Household
        • 7.2.2.2. Commercial
        • 7.2.2.3. Industrial
      • 7.2.3. Global Medicinal Fungi by: Form (Value)
        • 7.2.3.1. Powder
        • 7.2.3.2. Whole
        • 7.2.3.3. Slices
        • 7.2.3.4. Extract
      • 7.2.4. Global Medicinal Fungi by: End-use (Value)
        • 7.2.4.1. Antioxidants
        • 7.2.4.2. Immune enhancers
        • 7.2.4.3. Anti-cancer
        • 7.2.4.4. Skincare
      • 7.2.5. Global Medicinal Fungi Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Medicinal Fungi: by Type(USD Million)
  • Table 2. Medicinal Fungi Micafungin , by Region USD Million (2018-2023)
  • Table 3. Medicinal Fungi Mycophenolate , by Region USD Million (2018-2023)
  • Table 4. Medicinal Fungi Rosuvastatin , by Region USD Million (2018-2023)
  • Table 5. Medicinal Fungi Others , by Region USD Million (2018-2023)
  • Table 6. Medicinal Fungi: by Application(USD Million)
  • Table 7. Medicinal Fungi Household , by Region USD Million (2018-2023)
  • Table 8. Medicinal Fungi Commercial , by Region USD Million (2018-2023)
  • Table 9. Medicinal Fungi Industrial , by Region USD Million (2018-2023)
  • Table 10. Medicinal Fungi: by Form(USD Million)
  • Table 11. Medicinal Fungi Powder , by Region USD Million (2018-2023)
  • Table 12. Medicinal Fungi Whole , by Region USD Million (2018-2023)
  • Table 13. Medicinal Fungi Slices , by Region USD Million (2018-2023)
  • Table 14. Medicinal Fungi Extract , by Region USD Million (2018-2023)
  • Table 15. Medicinal Fungi: by End-use(USD Million)
  • Table 16. Medicinal Fungi Antioxidants , by Region USD Million (2018-2023)
  • Table 17. Medicinal Fungi Immune enhancers , by Region USD Million (2018-2023)
  • Table 18. Medicinal Fungi Anti-cancer , by Region USD Million (2018-2023)
  • Table 19. Medicinal Fungi Skincare , by Region USD Million (2018-2023)
  • Table 20. South America Medicinal Fungi, by Country USD Million (2018-2023)
  • Table 21. South America Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 22. South America Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 23. South America Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 24. South America Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 25. Brazil Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 26. Brazil Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 27. Brazil Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 28. Brazil Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 29. Argentina Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 30. Argentina Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 31. Argentina Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 32. Argentina Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 33. Rest of South America Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 34. Rest of South America Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 35. Rest of South America Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 36. Rest of South America Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 37. Asia Pacific Medicinal Fungi, by Country USD Million (2018-2023)
  • Table 38. Asia Pacific Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 39. Asia Pacific Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 40. Asia Pacific Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 41. Asia Pacific Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 42. China Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 43. China Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 44. China Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 45. China Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 46. Japan Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 47. Japan Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 48. Japan Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 49. Japan Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 50. India Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 51. India Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 52. India Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 53. India Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 54. South Korea Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 55. South Korea Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 56. South Korea Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 57. South Korea Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 58. Taiwan Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 59. Taiwan Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 60. Taiwan Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 61. Taiwan Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 62. Australia Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 63. Australia Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 64. Australia Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 65. Australia Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 70. Europe Medicinal Fungi, by Country USD Million (2018-2023)
  • Table 71. Europe Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 72. Europe Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 73. Europe Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 74. Europe Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 75. Germany Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 76. Germany Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 77. Germany Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 78. Germany Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 79. France Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 80. France Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 81. France Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 82. France Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 83. Italy Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 84. Italy Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 85. Italy Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 86. Italy Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 87. United Kingdom Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 88. United Kingdom Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 89. United Kingdom Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 90. United Kingdom Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 91. Netherlands Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 92. Netherlands Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 93. Netherlands Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 94. Netherlands Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 95. Rest of Europe Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 96. Rest of Europe Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 97. Rest of Europe Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 98. Rest of Europe Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 99. MEA Medicinal Fungi, by Country USD Million (2018-2023)
  • Table 100. MEA Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 101. MEA Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 102. MEA Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 103. MEA Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 104. Middle East Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 105. Middle East Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 106. Middle East Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 107. Middle East Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 108. Africa Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 109. Africa Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 110. Africa Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 111. Africa Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 112. North America Medicinal Fungi, by Country USD Million (2018-2023)
  • Table 113. North America Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 114. North America Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 115. North America Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 116. North America Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 117. United States Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 118. United States Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 119. United States Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 120. United States Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 121. Canada Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 122. Canada Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 123. Canada Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 124. Canada Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 125. Mexico Medicinal Fungi, by Type USD Million (2018-2023)
  • Table 126. Mexico Medicinal Fungi, by Application USD Million (2018-2023)
  • Table 127. Mexico Medicinal Fungi, by Form USD Million (2018-2023)
  • Table 128. Mexico Medicinal Fungi, by End-use USD Million (2018-2023)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Medicinal Fungi: by Type(USD Million)
  • Table 138. Medicinal Fungi Micafungin , by Region USD Million (2025-2030)
  • Table 139. Medicinal Fungi Mycophenolate , by Region USD Million (2025-2030)
  • Table 140. Medicinal Fungi Rosuvastatin , by Region USD Million (2025-2030)
  • Table 141. Medicinal Fungi Others , by Region USD Million (2025-2030)
  • Table 142. Medicinal Fungi: by Application(USD Million)
  • Table 143. Medicinal Fungi Household , by Region USD Million (2025-2030)
  • Table 144. Medicinal Fungi Commercial , by Region USD Million (2025-2030)
  • Table 145. Medicinal Fungi Industrial , by Region USD Million (2025-2030)
  • Table 146. Medicinal Fungi: by Form(USD Million)
  • Table 147. Medicinal Fungi Powder , by Region USD Million (2025-2030)
  • Table 148. Medicinal Fungi Whole , by Region USD Million (2025-2030)
  • Table 149. Medicinal Fungi Slices , by Region USD Million (2025-2030)
  • Table 150. Medicinal Fungi Extract , by Region USD Million (2025-2030)
  • Table 151. Medicinal Fungi: by End-use(USD Million)
  • Table 152. Medicinal Fungi Antioxidants , by Region USD Million (2025-2030)
  • Table 153. Medicinal Fungi Immune enhancers , by Region USD Million (2025-2030)
  • Table 154. Medicinal Fungi Anti-cancer , by Region USD Million (2025-2030)
  • Table 155. Medicinal Fungi Skincare , by Region USD Million (2025-2030)
  • Table 156. South America Medicinal Fungi, by Country USD Million (2025-2030)
  • Table 157. South America Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 158. South America Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 159. South America Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 160. South America Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 161. Brazil Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 162. Brazil Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 163. Brazil Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 164. Brazil Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 165. Argentina Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 166. Argentina Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 167. Argentina Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 168. Argentina Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 169. Rest of South America Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 170. Rest of South America Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 171. Rest of South America Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 172. Rest of South America Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 173. Asia Pacific Medicinal Fungi, by Country USD Million (2025-2030)
  • Table 174. Asia Pacific Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 175. Asia Pacific Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 176. Asia Pacific Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 177. Asia Pacific Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 178. China Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 179. China Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 180. China Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 181. China Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 182. Japan Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 183. Japan Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 184. Japan Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 185. Japan Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 186. India Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 187. India Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 188. India Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 189. India Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 190. South Korea Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 191. South Korea Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 192. South Korea Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 193. South Korea Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 194. Taiwan Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 195. Taiwan Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 196. Taiwan Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 197. Taiwan Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 198. Australia Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 199. Australia Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 200. Australia Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 201. Australia Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 202. Rest of Asia-Pacific Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 203. Rest of Asia-Pacific Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 204. Rest of Asia-Pacific Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 205. Rest of Asia-Pacific Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 206. Europe Medicinal Fungi, by Country USD Million (2025-2030)
  • Table 207. Europe Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 208. Europe Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 209. Europe Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 210. Europe Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 211. Germany Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 212. Germany Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 213. Germany Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 214. Germany Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 215. France Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 216. France Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 217. France Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 218. France Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 219. Italy Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 220. Italy Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 221. Italy Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 222. Italy Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 223. United Kingdom Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 224. United Kingdom Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 225. United Kingdom Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 226. United Kingdom Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 227. Netherlands Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 228. Netherlands Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 229. Netherlands Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 230. Netherlands Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 231. Rest of Europe Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 232. Rest of Europe Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 233. Rest of Europe Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 234. Rest of Europe Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 235. MEA Medicinal Fungi, by Country USD Million (2025-2030)
  • Table 236. MEA Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 237. MEA Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 238. MEA Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 239. MEA Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 240. Middle East Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 241. Middle East Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 242. Middle East Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 243. Middle East Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 244. Africa Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 245. Africa Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 246. Africa Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 247. Africa Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 248. North America Medicinal Fungi, by Country USD Million (2025-2030)
  • Table 249. North America Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 250. North America Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 251. North America Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 252. North America Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 253. United States Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 254. United States Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 255. United States Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 256. United States Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 257. Canada Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 258. Canada Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 259. Canada Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 260. Canada Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 261. Mexico Medicinal Fungi, by Type USD Million (2025-2030)
  • Table 262. Mexico Medicinal Fungi, by Application USD Million (2025-2030)
  • Table 263. Mexico Medicinal Fungi, by Form USD Million (2025-2030)
  • Table 264. Mexico Medicinal Fungi, by End-use USD Million (2025-2030)
  • Table 265. Research Programs/Design for This Report
  • Table 266. Key Data Information from Secondary Sources
  • Table 267. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Medicinal Fungi: by Type USD Million (2018-2023)
  • Figure 5. Global Medicinal Fungi: by Application USD Million (2018-2023)
  • Figure 6. Global Medicinal Fungi: by Form USD Million (2018-2023)
  • Figure 7. Global Medicinal Fungi: by End-use USD Million (2018-2023)
  • Figure 8. South America Medicinal Fungi Share (%), by Country
  • Figure 9. Asia Pacific Medicinal Fungi Share (%), by Country
  • Figure 10. Europe Medicinal Fungi Share (%), by Country
  • Figure 11. MEA Medicinal Fungi Share (%), by Country
  • Figure 12. North America Medicinal Fungi Share (%), by Country
  • Figure 13. Global Medicinal Fungi share by Players 2023 (%)
  • Figure 14. Global Medicinal Fungi share by Players (Top 3) 2023(%)
  • Figure 15. Global Medicinal Fungi share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Amino Up Chemical Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 18. Amino Up Chemical Co., Ltd. (Japan) Revenue: by Geography 2023
  • Figure 19. Nammex (Canada) Revenue, Net Income and Gross profit
  • Figure 20. Nammex (Canada) Revenue: by Geography 2023
  • Figure 21. Baikal Herbs Ltd. (Russia) Revenue, Net Income and Gross profit
  • Figure 22. Baikal Herbs Ltd. (Russia) Revenue: by Geography 2023
  • Figure 23. Hangzhou Johncan Mushroom Bio-Technology Co., Ltd (China) Revenue, Net Income and Gross profit
  • Figure 24. Hangzhou Johncan Mushroom Bio-Technology Co., Ltd (China) Revenue: by Geography 2023
  • Figure 25. Aloha Medicinals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Aloha Medicinals, Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Fungi Perfecti, Llc (United States) Revenue, Net Income and Gross profit
  • Figure 28. Fungi Perfecti, Llc (United States) Revenue: by Geography 2023
  • Figure 29. Undersun Biomedtech Corp (United States) Revenue, Net Income and Gross profit
  • Figure 30. Undersun Biomedtech Corp (United States) Revenue: by Geography 2023
  • Figure 31. NutraGenesis, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 32. NutraGenesis, LLC (United States) Revenue: by Geography 2023
  • Figure 33. Global Medicinal Fungi: by Type USD Million (2025-2030)
  • Figure 34. Global Medicinal Fungi: by Application USD Million (2025-2030)
  • Figure 35. Global Medicinal Fungi: by Form USD Million (2025-2030)
  • Figure 36. Global Medicinal Fungi: by End-use USD Million (2025-2030)
  • Figure 37. South America Medicinal Fungi Share (%), by Country
  • Figure 38. Asia Pacific Medicinal Fungi Share (%), by Country
  • Figure 39. Europe Medicinal Fungi Share (%), by Country
  • Figure 40. MEA Medicinal Fungi Share (%), by Country
  • Figure 41. North America Medicinal Fungi Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Amino Up Chemical Co., Ltd. (Japan)
  • Nammex (Canada)
  • Baikal Herbs Ltd. (Russia)
  • Hangzhou Johncan Mushroom Bio-Technology Co., Ltd (China)
  • Aloha Medicinals, Inc. (United States)
  • Fungi Perfecti, Llc (United States)
  • Undersun Biomedtech Corp (United States)
  • NutraGenesis, LLC (United States)
Additional players considered in the study are as follows:
Naturalin Bio-Resources Co., Ltd (China) , Lingonberry Group (USA) Inc. (United States) , Others
Select User Access Type

Key Highlights of Report


Apr 2024 226 Pages 67 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Medicinal Fungi Quantitative research analysis
Global Medicinal Fungi Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Amino Up Chemical Co., Ltd. (Japan), Nammex (Canada), Baikal Herbs Ltd. (Russia), Hangzhou Johncan Mushroom Bio-Technology Co., Ltd (China), Aloha Medicinals, Inc. (United States), Fungi Perfecti, Llc (United States), Undersun Biomedtech Corp (United States) and NutraGenesis, LLC (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increased Research and Development Funding" is seen as one of major influencing trends for Medicinal Fungi Market during projected period 2023-2030.
The Medicinal Fungi market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Medicinal Fungi Report?

Have a Query? Click Here

Other Related Reports

Chrysin Extract Comprehensive Study by Application (Food Additive, Cosmetics and Personal Care, Dietary Supplements, Pharmaceuticals, Others), Form (Liquid, Powder, Capsules), Distribution Channel (O...
$ 3450
Nano-drug Comprehensive Study by Type (Nanoparticles (Metal & Metal Oxide Nanoparticles, Liposomes, Polymers & polymer-drug conjugates, Hydrogel nanoparticles, Dendrimers, Inorganic nanoparticles), N...
$ 3750
Mice Model Comprehensive Study by Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Conditioned/Surgically Modified Mice), Application (Cancer Research, Inflammation...
$ 3750
Protein Purification & Isolation Comprehensive Study by End Users (Hospitals and Diagnostic Centers, Contract Research Organization, Academic Medical Institutes, Pharmaceuticals & Biotechnology), Pro...
$ 3800
Biologics Safety Testing Comprehensive Study by Type (Endotoxin Tests, Sterility Tests, Cell Line Authentication and Characterization Tests, Bioburden Tests, Cell Line Authentication, Residual Host C...
$ 3750
Stem Cell Assay Comprehensive Study by Type (Viability/Cytotoxicity, Isolation & Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis), Application (Regenerative Med...
$ 3750